Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

unknown1
Completed1
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown125%
completed125%
not_yet_recruiting125%
enrolling_by_invitation125%

Recent Activity

0 active trials
Showing 4 of 4
enrolling_by_invitationnot_applicable

Visuospatial and Affective Abilities in Parkinson Disease

NCT06341829
not_yet_recruiting

National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

NCT06876064
completed

Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives

NCT05319470
unknown

Effect of Eye Make up on Ocular Surface

NCT04478955

Clinical Trials (4)

Showing 4 of 4 trials
NCT06341829Not Applicable

Visuospatial and Affective Abilities in Parkinson Disease

Enrolling By Invitation
NCT06876064

National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

Not Yet Recruiting
NCT05319470

Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives

Completed
NCT04478955

Effect of Eye Make up on Ocular Surface

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4